FDA panel recommends birth control pill Opill be sold over the counter
The advisors' vote is not binding, and the FDA is expected to make a final decision this summer.
Source: northjersey.com
Stay updated with breaking news from Murrays Kessler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The advisors' vote is not binding, and the FDA is expected to make a final decision this summer.
The advisors' vote is not binding, and the FDA is expected to make a final decision this summer.
The advisors' vote is not binding, and the FDA is expected to make a final decision this summer.
The advisors' vote is not binding, and the FDA is expected to make a final decision this summer.
/PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO, Murray S. Kessler...